DEA Publishes Proposal to Reschedule Hydrocodone
Today the U. S. Drug Enforcement Administration (DEA) published in the Federal Register a Notice of Proposed Rulemaking (NPRM) to move hydrocodone combination products (HCPs) from Schedule III to Schedule II, as recommended by the Assistant Secretary for Health of the U.S. Department of Health and Human Services (HHS) and as supported by the DEA’s own evaluation of relevant data. This NPRM proposes to impose the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The public is invited to review the proposed rule, which is posted on the DEA’s website.
|FEB 24||DEA Statement on the Arrest of Joaquin "El Chapo" Guzman Loera|
|FEB 22||Dept. of Justice Statement on the Arrest of Joaquin "El Chapo" Guzman Loera|
|FEB 11||Maryland Science Center and DEA Open Powerful New Exhibit|
|JAN 10||DEA Official Appointed Vice-Chair to Newly Created National Commission On Forensic Science|
|DEC 20||DEA Statement on 2013 Monitoring the Future Study|